Insulin degludec/Insulin aspart (Chongqing Chenan Biopharma)
德谷胰岛素/门冬胰岛素（重庆宸安生物）
Report date: 2025/06/23 13:32:53
Base Information
Drug NameInsulin degludec/Insulin aspart (Chongqing Chenan Biopharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Chenan Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChongqing Chenan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A